Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan M Kaneda

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Immunology Research|October 1, 2017
PI3Kγ Activates Integrin α<sub>4</sub> and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor ProgressionPhilippe Foubert, Megan M Kaneda, Judith A Varner
Annals of Biomedical Engineering|February 3, 2009
Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeuticsMegan M Kaneda, Shelton Caruthers, Gregory M Lanza, et al.
Journal of Biomedical Materials Research. Part A|February 21, 2008
Endothelial cell migration in human plasma is enhanced by a narrow range of added sphingosine 1-phosphate: implications for biomaterials designShannon K Alford, Megan M Kaneda, Bradley K Wacker, et al.
Annals of Biomedical Engineering|September 1, 2005
Fluid shear stress modulates cell migration induced by sphingosine 1-phosphate and vascular endothelial growth factorShannon K Hughes, Bradley K Wacker, Megan M Kaneda, et al.
Biomaterials|January 23, 2010
Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsionsMegan M Kaneda, Yo Sasaki, Gregory M Lanza, et al.
Biomacromolecules|April 11, 2006
Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogelsBradley K Wacker, Evan A Scott, Megan M Kaneda, et al.
Nature Communications|April 2, 2022
PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammationMichael C Schmid, Sang Won Kang, Hui Chen, et al.
Clinical & Translational Immunology|November 25, 2024
Dual CD47 and PD-L1 blockade elicits anti-tumor immunity by intratumoral CD8<sup>+</sup> T cellsSusan N Christo, Keely M McDonald, Thomas N Burn, et al.
Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
Frontiers in Immunology|March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacyMithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Immunology Research|October 1, 2017
PI3Kγ Activates Integrin α<sub>4</sub> and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor ProgressionPhilippe Foubert, Megan M Kaneda, Judith A Varner
Annals of Biomedical Engineering|February 3, 2009
Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeuticsMegan M Kaneda, Shelton Caruthers, Gregory M Lanza, et al.
Journal of Biomedical Materials Research. Part A|February 21, 2008
Endothelial cell migration in human plasma is enhanced by a narrow range of added sphingosine 1-phosphate: implications for biomaterials designShannon K Alford, Megan M Kaneda, Bradley K Wacker, et al.
Annals of Biomedical Engineering|September 1, 2005
Fluid shear stress modulates cell migration induced by sphingosine 1-phosphate and vascular endothelial growth factorShannon K Hughes, Bradley K Wacker, Megan M Kaneda, et al.
Biomaterials|January 23, 2010
Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsionsMegan M Kaneda, Yo Sasaki, Gregory M Lanza, et al.
Biomacromolecules|April 11, 2006
Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogelsBradley K Wacker, Evan A Scott, Megan M Kaneda, et al.
Nature Communications|April 2, 2022
PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammationMichael C Schmid, Sang Won Kang, Hui Chen, et al.
Clinical & Translational Immunology|November 25, 2024
Dual CD47 and PD-L1 blockade elicits anti-tumor immunity by intratumoral CD8<sup>+</sup> T cellsSusan N Christo, Keely M McDonald, Thomas N Burn, et al.
Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
Frontiers in Immunology|March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacyMithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Pageof 2